The Latest

Spotlight on Innovation

Medication-assisted treatment (MAT) is critical for successful long-term management of opioid use disorder, allowing patients to focus on reintegrating into their lives and communities. Braeburn is working to deliver flexible-dose, next-generation therapies to manage this chronic brain disease – therapies that are administered directly by health care professionals, which may potentially minimize the risks of misuse and improve treatment adherence. Read more about MAT and Braeburn here.

News

Previous Events